Cross-Sector entity
All 1 tracked stories fall under one category: pharma. Lingang Special Area is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Zhangjiang Hi-Tech Park appears in 1 tracked Cross-Sector story from March 21, 2026. The tracked stories average 2 original sources each.
1 verified story tracked
Last mentioned: Mar 21, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Lingang Special Area is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Zhangjiang Hi-Tech Park appears in 1 tracked Cross-Sector story from March 21, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Zhangjiang Hi-Tech Park. Shared-story counts are live from our verified record — not editorial picks.
Shanghai Biopharma 3.0
Shanghai launches the third phase of its high-quality development action plan.
National Future Industry Guidelines
China MIIT releases the first national framework for developing 'future industries'.
Shanghai is aggressively implementing a new 'first-class business environment' framework designed to anchor its position as the global epicenter for 'Future Life' industries. The initiative prioritizes regulatory breakthroughs in gene therapy and synthetic biology while expanding the Zhangjiang-Lingang biopharma corridor.
Source: tucsonpost.com · shanghainews.net
